Quest for Novel Regenerative Medicine and Changes in Government Regulations Brighten Stem Cell Research Prospects, according to an Exclusive Report from RI Technologies.
Hyderabad, AP (PRWEB) July 16, 2012
Stem Cell Research has picked up pace like never before now. The science of stem cells is leading to evolution of cell-based therapies referred to as reparative or regenerative medicine for the treatment of diseases. The ongoing research on stem cells indicates the replenishment of damaged cells by healthy cells in adult organism and the origin of an organism through a single cell. Stem cell science is predicted to be the most promising field in Biology though it has its own share of queries and controversies.
Stem Cell Research is progressive yet mired in controversies. The technology is leading to a new kind of cell-based medicine that is regenerative in nature. However, practicality and ethics dominate the ever controversial subject. Hence, it may take some more time, before a proper worldwide consensus emerges on the usage and procedures of stem cell research. While some countries approve, some oppose. Stem cell research is most likely to gather pace in countries with less regulatory controls. Of all the countries, China has the most favorable environment for research. The UK too has a strong research presence. The United States is the leader in stem cell research. However, the government controls the grants for research but places no restrictions on funds from private, state, or local government resources.
Stem cells give advanced information about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms. This is a very promising area of science and has huge disease-curing applications. Stem cells are as much part of controversy as they are exciting. They possess the potential for curing diseases including Alzheimers, Diabetes, Huntingtons and Parkinsons. Stem cell research itself is controversial as the stem cells are derived from embryos. Growth of stem cells market worldwide is basically driven by the potential of stem cells for the various diseases. For example, embryonic stem cells are capable of generating new tissues and organs to replace the damaged tissues and organs.
Adult stem cells market is the largest tapped market while cord blood and embryonic stem cell markets, though with huge market potential, are still in infancy stages. The US is the leader followed by the European and Asia-Pacific regions. With government regulations being amended in several countries, Stem Cell Research is expected to pick up pace rapidly in the next few years.
Stem Cell technology is being increasing applied for the past decade to treat critical diseases and presently utilized for treatment of more than 70 diseases. Utility of stem cells in cosmetic and post injury healing therapy was also established recently. Umbilical cord is an abundant source of stem cells and the best advantage of this source is that it is a non-invasive procedure as cord blood and cord tissue are utilized to derive stem cells.
Stem cells are found in adult bone marrow and also in embryos. Adult stem cells have been used in disease treatment since long time. However, embryonic stem cell research is the topic of debate. The field can lead to great therapeutic treatments. But, due to its various ethical origins, is mired in debates all over the world. Embryonic stem cells have the potential to transform into any other type of cell (unlike adult stem cells). The huge potential for embryonic stem cells lies in finding treatments for liver disorders, neurodegenerative disorders, spinal cord injuries, cardiac diseases, cancers, diabetes, cosmetics, bone and cartilage diseases, ostroarthritis, rheumatoid arthritis, and a host of other life threatening diseases. The discovery of a second source of adult stem cells has given hope and great potential for the future of stem cell therapy.
Embryonic stem cell research evokes great excitement primarily due to the fact that embryonic stem cells can make so called regenerative medicine and be used in therapeutic cloning. Embryonic stem cell research has the potential to contribute to the management and treatment of a large number of diseases such as diabetes, spinal cord injuries, cardiac disease, Parkinsons and Alzheimers disease. Scientists can learn about human cell growth and development, and also to understand cancer better. However, controversial debates (ethical issues) in this area have led scientists to study more about adult stem cell research. However, embryonic stem cells still capture scientists fancy due to their enhanced proficiency at cell division and plasticity. Apart from the US (after initial bans), the UK, Belgium, Sweden, Japan, China and South Korea have allowed embryonic stem cell cloning. The EU also provides funds for countries undertaking embryonic stem cell research. President Obamas change in policy for embryonic stem cell research will open new doors for scientists. A lifting of restrictions also means that detailed guidelines have to be outlined and proper laws should be in place for the several issues in stem cell research.
Countries are competing globally for getting an edge in stem cell research as breakthrough technologies in this field would herald the countrys medical expertise and dominance. Research and laboratory technologies are also progressing rapidly. The potential of stem cell research both medically and economically, is leading to huge investments by biotechnology companies, pharmaceutical companies and governments too.
For more information about this report, please visit: http://www.researchimpact.com/MIR005_STEMCELLRESEARCH.aspx
Customer Support: contactus(at)researchimpact(dot)com.
Phone: +91 9676994272 / UK: 076-24-057837 for 24/7 online and offline support.
About RI Technologies
RI Technologies, http://www.researchimpact.com, is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company’s reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies’ research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.
(PRWEB) September 26, 2011
Stem cell treatment centers are open on both US coasts. So to facilitate Midwest clients, Stem Cell WI, will be opening a clinic soon in Madison, WI by Jane Langdon. Jane has seen the remarkable results of stem cell treatment on her husband and sister-in-law who have Parkinsons Disease.
They will only use your own adult stem cells for treatment. These stem cells are not subject to any ethical or moral issues. Treatments are available for COPD/Lung Conditions, Diabetes, Lupus, Osteoarthritis, Parkinson’s Disease, Rheumatoid Arthritis, Stroke, Multiple Sclerosis and Joint Repair.
Stem cells are early stage cells that have the ability to continuously divide and develop into other specialized types of cells. For example, stem cells can turn into liver cells, skin cells, nerve cells, etc. Like a blank microchip that can ultimately be programmed to perform any one of a number of specialized tasks, stem cells are undifferentiated cells that do not yet have a specific physiological function. When proper conditions occur in the body or lab, stem cells begin to develop into specialized tissues and organs. These cells may have differing abilities to turn into more specialized cells and are self-sustaining, replicating through cell division.
Patients have their fat stem cells (usually abdominal) harvested in our special sterile treatment facility under a local anesthetic. The fat removal procedure lasts approximately twenty minutes. Specially designed equipment is used to harvest the fat cells and less than 100cc of fat is required. Your stem cells a reintroduced into your body after cleaning and a special low laser application. Post-operative discomfort is minimal and there is minimal restriction on activity. There is no concern for rejection since they are from your own body.
Costs range from $ 14,000 to $ 18,000. This is a small price when you consider what you are paying now for Doctors, hospital care, medications, restricted lifestyle and pain.
Dallas, Texas (PRWEB) September 29, 2011
Join us for informational presentations by Stem Cell Institutes Medical Director, Dr. Jorge Paz Rodr
Worlds First Breakthrough Stem Cell Procedure on a Goat Performed in Kentucky Vet Clinic: Advanced Technology From MediVet-America Provides Animal Therapeutic Care
Nicholasville, KY (PRWEB) September 29, 2011
When Cinnamon, a seven-year-old, 325 pound goat, began receiving stem cell therapy on location at a veterinary clinic outside of Louisville, Kentucky, it was a medical first in the whole world for the animal kingdom.
The procedure at the Henry County Animal Clinic was performed by Dr. Clark Slone, DVM, to alleviate the pain Cinnamon suffered from a torn ACL and bad carpal joints.
Dr. Slone utilized the advanced, drug-free technology pioneered by MediVet-America (http://www.Medivet-America.com), a research and development company and global leader in veterinary stem cell technology and regenerative medicines.
Adult animal stem cell technology uses the bodys own regenerative healing power to help cure dogs, cats, horses and other animals suffering from arthritis, hip dysplasia and tendon, ligament and cartilage injuries and other ailments.
Fat tissue was removed from the animal, millions of stem cells were separated and activated on location through a patented L.E.D. technology, and then injected into the affected areas.
Within a month of the procedure, Cinnamon will be moving well, virtually pain free.
These stem cells are supercharged, theyre ready to work, and automatically go to the inflamed area in the body, said MediVet-Americas Brenda Timperman. The animals that were having problems recover and are a whole lot better.
Using MediVet-Americas new Adipose-Derived Stem Cell Procedure Kit, veterinary practitioners in 200 markets throughout 42 states now perform the drug-free procedure entirely in their own clinics more quickly, effectively and economically than first generation animal stem cell therapy. This new treatment, developed in Australia, is now available in 23 countries worldwide.
The stem cell advancements in veterinary medicine are paving the way for healthier and happier lives for pets in America.
Some areas of research and therapy are progressing faster than that in human medicine, said MediVet-America managing director Jeremy Delk. Stem cell therapy is at the leading edge of this evolution.
Stem cells are basic biological cells which have the ability to differentiate into specialized tissue cells and regenerate to additional cells. These new cells can be beneficial in replacing or repairing damaged tissue. The stem cells used in veterinary medicine arent embryonic, the type which have garnered much controversy over the years, but are taken from adipose (fat) tissue of the individual patient.
MediVet, the worlds leading animal stem cell company, is offering the newest and most advanced stem cell techniques that are changing the landscape of veterinary medicine. The regenerative cells are injected into the pets joints to encourage connective tissue like cartilage, tendons and ligaments to heal or grow including other degenerative diseases.
Delk said that trials, thousands of procedures and studies have shown significant improvement in quality of life for dogs, cats, and horses even Cinnamon the goat, camels and other wild animals with arthritis and other joint diseases.
More than 3,000 stem cell kits have been supplied to veterinarians across the U.S., who are seeing tremendous results. Animals that had been unable to climb stairs or walk well, are running and playing.
We have experienced tremendous growth this year in all areas of our business, said Delk. Were overwhelmed by the enthusiastic response weve received from pet owners and veterinarians around the world, and were deeply honored by the pet industrys acknowledgement of our services.
Excitement in the technology continues to grow as we are now seeing stem cell procedures happening everyday across the United States and the world.
Americans spent $ 48.3 billion in 2010 on their companion animals, according to the American Pet Products Association, up from $ 28.5 billion in 2001. The cost of a stem cell treatment is about $ 1,900 for small animals, $ 2,400 for horses. Stem cells also can be frozen and banked.
MediVet is seeking distributors in America and other parts of the world to serve its growing number of veterinarians and clinics.
We feel that it is an excellent opportunity for entrepreneurs who are interested in entering the expanding bio-medical field in a unique way, said Delk.
Delk said veterinarians can become in-house stem cell therapy clinics allowing them to perform procedures in real time for the small cost of necessary equipment of just $ 7,000.
IN THE NEWS: http://www.whas11.com/news/Stem-cell-therapy-breakthrough-benefits-goat-could-benefit-other-animals-130368428.html.
A research and development company and global leader in veterinary stem cell technology, MediVet-America provides innovative cell applications for the therapeutic care of animals. Headquartered in Nicholasville, Kentucky, MediVet-America develops advanced cellular designed kits and services for the treatment of osteoarthritis and degenerative joint disease. The company also offers MediVet Lab Services in multiple locations around the world that provides technical support for in-house stem cell vets, as well as regional and national Adipose stem cell processing and cyro banking services for pets at a young age or for a maintenance program, autologous conditioned serum processing, and cell counting for in-house stem cell procedures. Information on animal stem cell treatment and banking services are available at http://www.MediVet-America.com.
# # #
Find More Osteoarthritis Arthritis Press Releases
Stem Cell therapy is one form of Comprehensive Prolotherapy available for arthritis treatment, sports injury rehab, and chronic pain relief at Caring Medical and Rehabilitation Services. Our same-day procedure utilizes a person’s own mesenchymal stem cells from bone marrow to treat joint degeneration. It is an alternative to knee surgery, autologous chondrocyte implantation, and joint replacement surgery. In this video, the stem cell therapy treatment is demonstrated on an athlete with chondromalacia patella. Prolotherapy physician and Medical Director, Ross Hauser, MD explains how this Prolotherapy injection procedure works. To make an appointment for an opinion on your case and learn more about Prolotherapy, visit us at www.caringmedical.com
Veteran’s Day Honor: Search & Rescue Dogs of 9-11 Receive Breakthrough Stem Cell Regenerative Therapy from MediVet-America
Nashville, TN (PRWEB) November 10, 2011
One of the last surviving search & rescue dogs deployed in the 9/11 attacks, now 15 years old, will receive a breakthrough stem cell regenerative treatment from MediVet-America to help ease crippling arthritis and live out her days in greater comfort. At least two other 9/11 dogs also will receive the same stem cell therapy.
Only about a dozen of the nearly 100 search & rescue dogs that were sent to the World Trade Center in New York City, the Pentagon in Washington, D.C., and Shanksville, PA, are still alive today.
Bailey, a black Labrador retriever who is retired from service, will undergo the drug-free procedure on Veterans Day, Friday, Nov. 11, 2011, 10 a.m., at Companion Animal Hospital, in Goodlettsville, TN, near Nashville. It will be performed by Dr. Mary Ergen, D.V.M., and Katherine Wilkie, director of lab services for MediVet-America, which is donating the procedure.
Along with her handler, Keith Lindley of Thompson Station, TN, Bailey was mobilized by FEMA to the Pentagon on September 12, 2001. For 11 days she searched the disaster site and acted as a therapy dog for the first responders and military personnel who were devastated by the experience and missing their own families and pets. Later, Bailey went to Salt Lake City, UT, for the 2002 Winter Olympics and did wilderness searches back home. Today, she is stiff-legged from severe arthritis.
It seems fitting that on Veterans Day, when we honor all who have served our country, we are helping one of the unsung heroes of 9-11, said Lindley. I saw firsthand how Bailey and the other search & rescue dogs made a big difference in a terrible tragedy. And she may have many good years ahead. Her mother is now 18 years old.
Also to receive stem cell treatment in the coming weeks is Red, a 12 year old black Lab who was sent to the Pentagon on September 16 with her handler, Heather Roche of Annapolis, MD. Red also worked for 11 days, finding the remains of victims in the north parking-lot area. She later responded to Hurricanes Katrina and Rita. No longer able to handle tasks like climbing a two-story ladder, Red retired in July. Ms. Roche said, Red wants to work, but her body just cant do it anymore.
A third 9/11 search & rescue dog that searched the ruins at Ground Zero, Hoke, owned by Julie Noyes of Indiana, also will be treated.
Veterinarians and researchers describe stem cell regenerative therapy as a major scientific development in the treatment of arthritis, hip dysplasia, ligament and cartilage injuries and other degenerative joint diseases in dogs, cats, horses and other animals. The technology uses an adult animals own stem cells to heal itself.
MediVet-Americas treatment involves removing fat tissue from the animal, separating the stem cells from the fat, activating and then injecting the cells into the affected areas. Within four to six weeks, animals that had been in severe pain with a restricted range of motion are able to walk, run and even jump again.
The key to the procedure is an advanced, patented L.E.D. technology that activates millions of dormant stem cells present in fat tissue.
We are proud to help the unsung canine heroes of 9-11 on this first Veterans Day following the 10th anniversary of the attacks, said MediVet-America managing director Jeremy Delk. They deserve the very best stem cell therapeutic care that is now being received by animals across the nation.
The worlds leading research and development company in veterinary stem cell technology, MediVet-America provides innovative cell applications for the therapeutic care of animals. Headquartered in Nicholasville, Kentucky, MediVet-America develops advanced cellular designed kits and services for the treatment of osteoarthritis and degenerative joint disease. The company also offers MediVet Lab Services in multiple locations around the world that provides technical support for in-house stem cell vets, as well as regional and national Adipose stem cell processing and cyro banking services for pets at a young age or for a maintenance program, autologous conditioned serum processing, and cell counting for in-house stem cell procedures. [http://www.MediVet-America.com
EDITORS NOTE: The media is invited to cover the procedure at the Companion Animal Hospital, 121 Two Mile Pike, Goodlettsville, TN 32072. To arrange interviews, photographs and videotaping, contact Roberts Communications.
Photo of Bailey: http://www.nytimes.com/interactive/2011/08/14/magazine/14Mag-rescue-dogs.html#5
Find More Osteoarthritis Arthritis Press Releases
Sartell, MN (PRWEB) June 18, 2012
Rejuv Medical in Sartell, MN is quickly becoming the go-to resource for people in perfect health or those suffering from a variety of medical issues. The company is offering two types of stem-cell treatments. Dr. Joel Baumgartner is a board certified physician with specialized fellowship training in non-surgical orthopedics and sports medicine. Rejuv Medical is under Dr. Baumgartners direction, as are all stem-cell treatments performed at the Sartell location.
The stem-cell treatments offered by Rejuv Medical are non-controversial. Since the treatments are derived from the patients own body, not from a donor, there is no risk of rejection or cross infection. The company is using a persons very own cells, concentrating the cells and putting them into the area of degeneration. A person suffering with consistent pain no longer has to consider making a moral compromise when selecting stem-cell treatment. Many medical studies cite stem cells have the capability to regenerate cartilage, ligaments and tendons. With the current research, and success of stem cell procedures, many Orthopedic conditions that currently require surgery probably will become obsolete.
Rejuv Medical offers Regenerative Stem Cell-SD (Same Day) – A bone marrow based stem cell procedure, and Regenerative Stem Cell-SCP – (Stem Cell Plasma) which is performed through an IV blood draw. Both of these treatments are Regenexx
Stem cells for ailing dogs
Brian Albert Broom/The Clarion-Ledger Through MediVet-America's patented technology, thousands of animals have been treated with stem cell therapy for a range of degenerative diseases including hip dysplasia, arthritis, damaged tendons and ligaments.
Read more on Jackson Clarion Ledger
Consumer Reports: Something's fishy about fish oil
Fish oil supplements have become wildly popular, with consumers taking them to treat a long list of ailments including heart disease, high blood pressure, arthritis, stroke, weak bones, weight loss and high cholesterol, according to Megan Cleveland, …
Read more on Sioux City Journal
Researchers step closer to treating 'inflammatory' molecules behind diabetes …
Researchers at Cedars-Sinai have moved a step closer to better treatment of arthritis, diabetes and a number of other diseases caused in part by inflammation, and it all starts with a tiny molecule. The new finding may help create medications that will …
Read more on 89.3 KPCC
Search Dog From 9/11 Receives Stem Cell Treatment
On Monday, Red, who is now 12 years old, received a breakthrough stem cell regenerative treatment from Dr. John Herrity, DVM, at the Burke Animal Clinic to help ease crippling arthritis and live out her days in greater comfort.
Read more on Patch.com
Arthritic Youth Using Natural Treatments
On top of their doctor-prescribed treatments, many adults with arthritis choose to use natural remedies to deal with their pain. Natural treatments also seem to be a popular option among young arthritis patients. In a recent study, a majority of …
Read more on dailyRx
Nektar Reports that Partner Affymax Has Announced FDA Approval of OMONTYS …
Nektar's technology has now enabled eight approved products in the US or Europe through partnerships with leading biopharmaceutical companies, including Affymax's OMONTYS®, UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Pfizer's Somavert® …
Read more on MarketWatch (press release)
(PRWEB) February 16, 2012
World Stem Cells, LLC. contract laboratory Advanced Cellular Engineering Lab (Ingenieria Celular Advanzada S.A. de C.V.) a new adult stem cell laboratory being built in Cancun, Mexico to support Stem Cell research, stem cell clinical trials and stem cell treatments. This was accomplished by private funding in conjunction with World Stem Cells, LLC worldstemcells.com a US patient management company, Medicina Biocelular Avanzada , S.E. de C.V. a Mexican patient management company and Advanced Cellular Medicine Clinic of Cancun, a Stem Cell treatment Clinic owned and operated by Dr. Sylvia M. Abblitt a well known board certified hematologist and oncologist, in Cancun.
Uniquely, Dr. Abblitt is one of a limited number of physicians licensed to perform autologous and allogeneic stem cell transplants. Dr. Abblitt has been utilizing stem cell therapies with successes for many years.
She is the president and lab director of Advanced Cellular Engineering Lab (Ingenieria Celular Advanzada S.A. de C.V.). Her extensive background includes having been the laboratory director and head of hematology for Hospital Fernando Quiroz for 11 years. As a pioneer in the stem cell transplant field, she brings a vast array of knowledge to the lab. Her memberships include the american association of blood banks (aabb), Mexican society of transfusional medicine, interamerica society of transfusional medicine, Mexican association) for studies of hematologyandicms and ICMS (international cellular medical society and all patients are monitored by ICMS an independent agency for a period of between 2-20 years on a quarterly basis. Dr. abblitt has had a 26-year clinical practice history.
The laboratory construction is complete and operations were transferred to our new facility. This facility provides Cancun, and patient around the world, a state of the art GLP laboratory to support their stem cell treatments in a beautiful, and positive environment. The lab was designed and constructed to provide one ISO7 lab, one wet lab along with a treatment area. This will allow stem cell retrieval, testing, culturing, selection, counting, analyses and sorting along with cryopreservation, without removal from the lab. This all in house capability reduces the possibility of contamination and errors. Dr. M. Abblitt will operate the Lab under cGMP/cGLP guidelines and use the state of the art facility to provide quality care to her stem cell transplant patients.
Working under the guidelines set forth by ICMS world stem cells, LLC ( http://worldstemcells.com/ ) provides stem cell treatment for ankylosing spondylitis, autism, cerebral palsy, charcot-marie-tooth disease (cmt), crohns diseases, copd, fuchs disease, guillain-barre syndrome, hashimotos thryroiditis, itp, kidney diseases, macular degeneration, lupus (sle), multiple sclerosis, pad, parkinsons disease, rheumatoid arthritis, scleroderma, stroke, ulcerative colitis
The laboratory will be engaged in private clinical trials, IRBs and joint studies with US companies, Mexican Educational Institutes, US universities and doctors to better understand the benefits and precaution to be taken in the stem cell treatment process.
Find More Rheumatoid Arthritis Press Releases